TABLE 2.
Vestibular schwannoma specimen |
miR-513 Ct | U6 Ct | miR-513 Ct/U6 Ct | B7-H1 mRNA Ct | B7-H1 copy/µl | Actin copy/µl | B7-H1/actin ratio |
---|---|---|---|---|---|---|---|
B7-H1 (2+) A | 59.6 | 29.88 | 1.99 | 35.0 | 1440 | 4300 | 0.33 |
B7-H1 (2+) B | 46.7 | 32.11 | 1.45 | 35.1 | 1380 | 1790 | 0.77 |
B7-H1 (2+) C | 43.31 | 31.71 | 1.37 | 37.2 | 716 | 751 | 0.95 |
B7-H1 (2+) D | ND | ND | ND | 34.8 | 1580 | 3200 | 0.49 |
B7-H1 (2+) E | ND | ND | ND | 33.1 | 4060 | 4250 | 0.96 |
Average (2+) | 1.60 ± 0.34 (p = 0.62) | 0.70 ± 0.28 (p = 0.35) | |||||
B7-H1 (0) F | 46.84 | 33.13 | 1.41 | 35.9 | 1020 | 1140 | 0.89 |
B7-H1 (0) G | 49.47 | 30.29 | 1.63 | 35.9 | 1020 | 2310 | 0.44 |
B7-H1 (0) H | 41.51 | 30.31 | 1.37 | 36.3 | 900 | 880 | 1.02 |
B7-H1 (0) I | ND | ND | ND | 34.7 | 1690 | 1130 | 1.50 |
B7-H1 (0) J | ND | ND | ND | 36.3 | 900 | 1130 | 0.80 |
Average (0) | 1.47 ± (p = 0.62) | 0.93 ± 0.38 (p = 0.35) | |||||
H69 | 47.15 | 27.84 | 1.69 | ND | ND | ND | ND |
Tonsil | 0 | 30.21 | 0 | 32.1 | 2750 | 13200 | 0.21 |
RNA was available for only 3 positive and negative tumors for miR-513, which were normalized with small nuclear RNA RNU6 (U6). All 10 tumors were used to evaluate B7-H1 mRNA expression. Ct values were normalized to a standard curve of serial dilutions of a known B7-H1 RNA concentration (copy/µl). This was then normalized against actin mRNA copy/µl in the last column. Human cholangiocyte cells (H69) were used as a positive control, and human tonsil tissue was used as a negative control. No difference in the quantity of miR-513 or B7-H1 mRNA was detected between groups of strongly positive and negative B7-H1 protein immunostained VS (p = 0.62 and p = 0.35, respectively).
Bold values are the average miR-513 Ct/U6 Ct and B7-H1/actin ratio values for the B7-H1 2+ and negative (0) immunostaining schwannoma tumors.
ND indicates not determined.